On Monday, Livent stock hit a key performance benchmark, seeing its Relative Strength (RS) Rating jump into the 90-plus percentile with an improvement to 93, up from 87 the day before.
When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength. IBD's unique rating tracks share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains often have an RS Rating north of 80 at the beginning of a new run.
See How IBD Helps You Make More Money In Stocks
Is Livent Stock A Buy?
Livent stock has been trading in a consolidation and staying above its 50- and 200-day moving average, a good sign. While chemical stock is not near an ideal entry right now, see if it manages to form and break out of a proper chart pattern. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
In terms of fundamentals, the company has posted two quarters of accelerating earnings growth. Sales gains have also moved higher during the same period.
Livent stock holds the No. 1 rank among its peers in the Chemicals-Specialty industry group. Valhi and Ashland Global are also among the group's highest-rated stocks.
